A Study of LY2181308 in Patients With Advanced Hepatocellular Carcinoma

Mise à jour : Il y a 4 ans
Référence : NCT00415155

Femme et Homme

Extrait

The primary objective of this study is to estimate the time to progressive disease for patients with advanced hepatocellular cancer who receive LY2181308.


Critère d'inclusion

  • Hepatocellular carcinoma


Liens